These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26787696)

  • 1. Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.
    Hoang KV; Curry H; Collier MA; Borteh H; Bachelder EM; Schlesinger LS; Gunn JS; Ainslie KM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2052-62. PubMed ID: 26787696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection.
    Hoang KV; Borteh HM; Rajaram MV; Peine KJ; Curry H; Collier MA; Homsy ML; Bachelder EM; Gunn JS; Schlesinger LS; Ainslie KM
    Int J Pharm; 2014 Dec; 477(1-2):334-43. PubMed ID: 25447826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo and Cellular Trafficking of Acetalated Dextran Microparticles for Delivery of a Host-Directed Therapy for Salmonella enterica Serovar Typhi Infection.
    Johnson MM; Collier MA; Hoang KV; Pino EN; Graham-Gurysh EG; Gallovic MD; Zahid MSH; Chen N; Schlesinger L; Gunn JS; Bachelder EM; Ainslie KM
    Mol Pharm; 2018 Nov; 15(11):5336-5348. PubMed ID: 30296381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallium Potentiates the Antibacterial Effect of Gentamicin against Francisella tularensis.
    Lindgren H; Sjöstedt A
    Antimicrob Agents Chemother; 2016 Jan; 60(1):288-95. PubMed ID: 26503658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles.
    Collier MA; Peine KJ; Gautam S; Oghumu S; Varikuti S; Borteh H; Papenfuss TL; Sataoskar AR; Bachelder EM; Ainslie KM
    Int J Pharm; 2016 Feb; 499(1-2):186-194. PubMed ID: 26768723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal interleukin-12 treatment promotes antimicrobial clearance and survival in pulmonary Francisella tularensis subsp. novicida infection.
    Pammit MA; Budhavarapu VN; Raulie EK; Klose KE; Teale JM; Arulanandam BP
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4513-9. PubMed ID: 15561819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia.
    Hall CA; Flick-Smith HC; Harding SV; Atkins HS; Titball RW
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7206-7215. PubMed ID: 27671061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies.
    Conlan JW; Chen W; Shen H; Webb A; KuoLee R
    Microb Pathog; 2003 May; 34(5):239-48. PubMed ID: 12732472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Francisella tularensis LVS infection of macrophages results in a reduced inflammatory response: evaluation of a therapeutic strategy for intracellular bacteria.
    D'Elia R; Jenner DC; Laws TR; Stokes MG; Jackson MC; Essex-Lopresti AE; Atkins HS
    FEMS Immunol Med Microbiol; 2011 Aug; 62(3):348-61. PubMed ID: 21569124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization of intracellular Salmonella enterica serovar Typhimurium to aminoglycosides in vitro and in vivo by a host-targeted antimicrobial agent.
    Lo JH; Kulp SK; Chen CS; Chiu HC
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7375-82. PubMed ID: 25267669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-exposure immunization against Francisella tularensis membrane proteins augments protective efficacy of gentamicin in a mouse model of pneumonic tularemia.
    Sutherland MD; Goodyear AW; Troyer RM; Chandler JC; Dow SW; Belisle JT
    Vaccine; 2012 Jul; 30(33):4977-82. PubMed ID: 22652404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse model of oral infection with virulent type A Francisella tularensis.
    KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W
    Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Francisella tularensis as a potential agent of bioterrorism?
    Maurin M
    Expert Rev Anti Infect Ther; 2015 Feb; 13(2):141-4. PubMed ID: 25413334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of tularemia, including pulmonary tularemia, with gentamicin.
    Mason WL; Eigelsbach HT; Little SF; Bates JH
    Am Rev Respir Dis; 1980 Jan; 121(1):39-45. PubMed ID: 7352712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
    Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J
    Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent.
    Chiu HC; Soni S; Kulp SK; Curry H; Wang D; Gunn JS; Schlesinger LS; Chen CS
    J Biomed Sci; 2009 Dec; 16(1):110. PubMed ID: 20003180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyD88-dependent signaling prolongs survival and reduces bacterial burden during pulmonary infection with virulent Francisella tularensis.
    Russo BC; Brown MJ; Nau GJ
    Am J Pathol; 2013 Oct; 183(4):1223-1232. PubMed ID: 23920326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of acetalated dextran can be broadly tuned based on cyclic acetal coverage and molecular weight.
    Chen N; Collier MA; Gallovic MD; Collins GC; Sanchez CC; Fernandes EQ; Bachelder EM; Ainslie KM
    Int J Pharm; 2016 Oct; 512(1):147-157. PubMed ID: 27543351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
    Piercy T; Steward J; Lever MS; Brooks TJ
    J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.